Effect of small interfering RNA transfection on FAK and DLC1 mRNA expression in OVCAR-3

被引:9
作者
Shi, HuiRong [1 ]
Liu, HuiNa [1 ,2 ]
Zhao, GuoQiang [3 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Zhengzhou 450052, Peoples R China
[2] Zhengzhou Univ, Zhengzhou Cent Hosp, Dept Obstet & Gynecol, Zhengzhou 450007, Peoples R China
[3] Zhengzhou Univ, Coll Basical Sci, Zhengzhou 450001, Henan, Peoples R China
关键词
pGFP-siFAK-DLC1; vector; pGFP-siCon-DLC1; Transfection; OVCAR-3; siRNA; FAK; DLC1; FOCAL ADHESION KINASE; GTPASE-ACTIVATING PROTEIN; OVARIAN-CANCER; CELL-PROLIFERATION; RESISTANCE; IDENTIFICATION; TRANSFORMATION; METASTASIS; APOPTOSIS; MIGRATION;
D O I
10.1007/s11033-012-1724-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA interference is an evolutionarily conserved cellular defense mechanism that protects cells from hostile genes and regulates the function of normal genes during growth and development. In this study, we established GFP-siFAK-DLC1 vector and transfect the vector into OVCAR-3 cells. RT-PCR and western blot analyses were performed for FAK, DLC1 mRNA, and protein expression in OVCAR-3 cells. ELISA method was used for caspase-3 and caspase-9 activities. These studies demonstrate that both recombinant pGFP-siFAK-DLC1 vector and pGFP-siCon-DLC1 vector may effectively promote DLC1 mRNA transcription and didn't affect siRNA effect. Recombinant vector (pGFP-siFAK-DLC1) may promote DLC1 gene expression, and effectively silence FAK gene expression. Silencing FAK mRNA expression and DLC1 mRNA expression may markedly enhance caspase-3 and caspase-9 activities in OVCAR-3 cells. These results showed that in ovarian cancer OVCAR-3 cell silencing FAK gene expression or / and increasing DLC-1 gene expression, could improve Caspase-3 and Caspase-9 protease activities. In the expression of DLC-1 and silence FAK expression group (double action group) effect was more significant as compared with the silence FAK gene group or expression of DLC-1 gene alone, difference was significant (p < 0.05).
引用
收藏
页码:9299 / 9306
页数:8
相关论文
共 44 条
[1]   RNAi therapeutics: Principles, prospects and challenges [J].
Aagaard, Lars ;
Rossi, John J. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :75-86
[2]   Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].
Agarwal, R ;
Kaye, SB .
NATURE REVIEWS CANCER, 2003, 3 (07) :502-516
[3]   Nonviral delivery of synthetic siRNAs in vivo [J].
Akhtar, Saghir ;
Benter, Ibrahim F. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3623-3632
[4]   Ovarian surface epithelium: Biology, endocrinology, and pathology [J].
Auersperg, N ;
Wong, AST ;
Choi, KC ;
Kang, SK ;
Leung, PCK .
ENDOCRINE REVIEWS, 2001, 22 (02) :255-288
[5]   DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC) [J].
Baik, Seung-Ho ;
Jee, Bo-Keun ;
Choi, Jin-Soo ;
Yoon, Hyoung-Kyu ;
Lee, Kweon-Haeng ;
Kim, Yeul-Hong ;
Lim, Young .
MOLECULAR BIOLOGY REPORTS, 2009, 36 (07) :1767-1778
[6]   FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion [J].
Benlimame, N ;
He, Q ;
Jie, S ;
Xiao, DZ ;
Xu, YJ ;
Loignon, M ;
Schlaepfer, DD ;
Alaoui-Jamali, MA .
JOURNAL OF CELL BIOLOGY, 2005, 171 (03) :505-516
[7]   Fak/Src signaling in human intestinal epithelial cell survival and anoikis:: Differentiation State-specific uncouplin with the P13-K/Akt-1 ang MEK/Erk pathways [J].
Bouchard, Vtronique ;
Demers, Marie-Josee ;
Thibodeau, Sonya ;
Laquerre, Vincent ;
Fujita, Naoya ;
Tsuruo, Takashi ;
Beaulieu, Jean-Francois ;
Gauthier, Remy ;
Vezina, Anne ;
Villeneuve, Lisabeth ;
Vachon, Pierre H. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 212 (03) :717-728
[8]   Cancer of the ovary [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529
[9]   Expansion and evolution of cell death programmes [J].
Degterev, Alexei ;
Yuan, Junying .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (05) :378-390
[10]   The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer [J].
Dillon, R. L. ;
White, D. E. ;
Muller, W. J. .
ONCOGENE, 2007, 26 (09) :1338-1345